CMD Cantel Medical Corp

Cantel Medical Corp. (NYSE: CMN), through its Mar Cor Purification subsidiary, has expanded its infection prevention and control business in water treatment by purchasing the assets of Fluid Solutions, Inc. Fluid Solutions, based in Lowell, Massachusetts, designs, manufactures, installs and services high quality, high purity water systems for use in biotech, pharmaceutical, research, hospitals, and semiconductor environments. For the year ended April 30, 2006, Fluid Solutions generated approximately $5,000,000 in revenue. Mr. Andrew A. Krakauer, Executive Vice President and Chief Operating Officer of Cantel, stated, "Fluid Solutions' strong brand name in New England, superb service capability and a proven track record of innovative design, is a perfect fit for our Mar Cor Purification subsidiary. Through this acquisition we have added an additional outstanding team and base of business in a highly desirable region - one with great concentration of life sciences companies as well as healthcare and research institutions. We anticipate growing our business in Fluid Solutions' key markets, as well as expanding further into the healthcare and industrial arena. We foresee a number of operating synergies that will help drive both top line and bottom line performance." Mar Cor Purification will be retaining the employees of Fluid Solutions, including its President, Mr. Brian Hagopian, who has entered into a three-year employment agreement. Fluid Solutions, founded in 1989 and based in Lowell, MA, designs and manufactures high purity water systems, conducts installation and testing, performs maintenance, and provides resin regeneration services. The Company has developed a reputation of providing high purity water for high end water users and has deployed systems in biotech, pharmaceutical, research, hospitals, semiconductor and other industrial settings. Its founder and current President, Mr. Brian Hagopian, has worked in the water industry since 1981. Fluid Solutions was a wholly-owned subsidiary of DENS Partners, Inc. For further information, visit the Fluid Solutions web site at http://www.fluid-solutions.com. Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, endoscopy and surgical products, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. The Company also sells scientific instrumentation products, provides technical maintenance for its products and offers compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel web site at http://www.cantelmedical.com and the Mar Cor Purification web site at http://www.marcorpurification.com. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.